Produce change and drug discontinuation
Newsroom
August 2025 formulary update - effective August 14, 2025
Included in the update:
On behalf of the project team, Dr Becky Temple and Crystal Rollings would like to thank everyone for their invaluable contributions and feedback regarding the current Northern Health (NH) medical staff rules.
As a physician, you know the importance of delivering timely, high-quality care, especially in a region that continues to grow and evolve.
Update: As of July 2025, the BC Centre for Disease Control (BCCDC) has replaced Prevnar 13 and Pneumovax 23 with Prevnar 20 as the publicly funded vaccine. Prevnar 20 has the same indications with broader disease coverage in older adults and the young.
Classification: Cholinergic agonist
Indication: Induction of miosis
The issue: Odan previously issued a voluntary, type 3 recall for one lot of lidocaine 12 mg/dose endotracheal spray. This recall was due to a potential for the dispenser to leak. Type 3 recalls are defined by Health Canada as unlikely to cause adverse health effects.